What Is Retatrutide?

The Next Generation of Metabolic Weight-Loss Therapy

Retatrutide is one of the most exciting developments currently being studied in medical weight management.

Unlike earlier medications that target one or two metabolic pathways, retatrutide works on three different hormone receptors at the same time: GLP-1, GIP and glucagon.

That triple-action approach is why researchers are so interested in its potential effects on appetite, metabolism, body fat, blood sugar regulation, waist circumference and overall metabolic health.

At YES MD Atlanta, we closely follow advances in weight-loss medicine because understanding how these therapies work allows us to help patients make better decisions about their long-term health.
Tirzepatide-Semaglutide-Retatrutide-at-YES-MD-GLP1-s-Weight-Loss-in-Marietta-GA at YES MD Dr Assisted Weight Loss

How Does Retatrutide Work?

Retatrutide is known as a triple hormone receptor agonist.

It activates:

GLP-1

GLP-1 helps regulate appetite and satiety, allowing many patients to feel satisfied with less food. It also plays an important role in blood sugar regulation and digestion.

GIP

GIP is another metabolic hormone involved in insulin response, nutrient processing and energy balance.

Glucagon

The addition of the glucagon receptor is what makes retatrutide particularly interesting.

Glucagon has effects beyond blood sugar regulation. It is also involved in energy expenditure, appetite signaling and fat metabolism.

Researchers believe that combining all three pathways may help address weight management from several directions simultaneously.

Retatrutide and Abdominal Fat

For many patients, one of the most frustrating areas of weight gain is the midsection.

Abdominal weight often becomes increasingly difficult to manage with age, hormonal changes, insulin resistance and declining muscle mass.

 

Retatrutide research has shown meaningful reductions in waist circumference alongside overall weight loss.

In the Phase 2 obesity study, average waist reductions ranged from approximately 6.5 cm to nearly 20 cm, depending on the treatment group.

That makes abdominal and metabolic health an especially interesting area of ongoing research.

Does Retatrutide Work Better for Women or Men?

This is one of the more interesting findings from the early research.

Both men and women experienced substantial weight loss.

However, a prespecified analysis in the Phase 2 obesity study found that women experienced greater average percentage weight loss than men at some of the higher studied doses.

For example, in two higher-dose groups, average reductions among women were approximately 27–29%, compared with roughly 20–22% among men.

Researchers do not yet know exactly why.

Possible explanations may involve differences in:

 More research is needed before we can say that retatrutide is inherently “better” for women.

What we can say is that the early results in women have been particularly interesting.

Tirzepatide-Semaglutide-Retatrutide-at-YES-MD-GLP1-s-Weight-Loss-in-Marietta-GA at YES MD Dr Assisted Weight Loss

Retatrutide and Fatty Liver

Another particularly interesting area of research involves the liver.

 

Metabolic dysfunction-associated steatotic liver disease—often referred to as fatty liver disease—is closely associated with obesity, insulin resistance and metabolic dysfunction.

Studies of retatrutide have reported substantial reductions in liver fat in some participants.

This is one of several reasons researchers are studying retatrutide not simply as a weight-loss medication, but as a potential therapy for a broader range of obesity-related metabolic conditions.

Tirzepatide-Semaglutide-Retatrutide-at-YES-MD-GLP1-s-Weight-Loss-in-Marietta-GA at YES MD Dr Assisted Weight Loss

Can Retatrutide Improve Blood Sugar and Metabolic Health?

Clinical studies have reported improvements in several important metabolic measurements, including:

 In an earlier obesity trial, many participants who began the study with prediabetes returned to normal blood-sugar levels during treatment.

Retatrutide is also being studied specifically in people with type 2 diabetes.

This reinforces an important point:

Medical weight loss isn’t simply about appearance.

Improving metabolic health can influence many aspects of long-term wellness.

Does Retatrutide Increase Energy?

This question needs an important distinction.

Researchers have not established that retatrutide directly makes people feel more energetic.

However, the glucagon pathway is associated with energy expenditure, meaning the amount of energy the body uses.

That is one of the mechanisms scientists believe may distinguish retatrutide from medications that primarily focus on appetite.

In real life, patients who improve their weight, metabolic health, sleep, mobility and blood sugar may also experience changes in how energetic they feel—but that is different from saying retatrutide itself is an energy medication.

Why Is Retatrutide Different From Semaglutide and Tirzepatide?

Think of these medications as different generations of metabolic therapy.

Semaglutide:
GLP-1

Tirzepatide:
GIP + GLP-1

Retatrutide:
GIP + GLP-1 + Glucagon

Retatrutide’s third pathway may help explain why the weight-loss results seen in clinical studies have generated so much attention.

What Kind of Weight Loss Are Researchers Seeing?

The results have been significant.

In a Phase 2 obesity trial, participants receiving the higher studied doses experienced average weight reductions exceeding 20% of their starting body weight at 48 weeks, with some groups approaching approximately 24%.

More recent Phase 3 research has continued to show substantial weight reduction, including an average reduction of approximately 28% at 80 weeks in one higher-dose study group.

That represents a major change in what researchers have historically expected from medication-assisted weight management.

Individual results, of course, vary considerably.

Tirzepatide-Semaglutide-Retatrutide-at-YES-MD-GLP1-s-Weight-Loss-in-Marietta-GA at YES MD Dr Assisted Weight Loss

What About Cortisol?

Cortisol plays an important role in stress response, blood sugar regulation, appetite and the accumulation of abdominal fat.

It is therefore understandable that patients ask whether newer metabolic therapies such as retatrutide directly reduce cortisol.

 

At this time, there isn’t enough clinical evidence to say retatrutide is a cortisol-lowering medication.

At YES MD, we prefer to look at the bigger picture.

Stress, sleep, hormones, thyroid function, nutrition, blood sugar and metabolism all interact.

If a patient is struggling with stubborn abdominal weight, fatigue or other metabolic symptoms, those factors deserve to be evaluated rather than assuming that one medication addresses everything.

Tirzepatide-Semaglutide-Retatrutide-at-YES-MD-GLP1-s-Weight-Loss-in-Marietta-GA at YES MD Dr Assisted Weight Loss

Who Appears to Respond Particularly Well?

Modern weight-loss medications can be powerful tools, but long-term success requires a broader strategy.

Research to date suggests that substantial weight loss has occurred across a broad range of adults with obesity.

Two groups stood out in the earlier obesity research:

People With Higher Starting BMI

Participants beginning with a BMI of 35 or greater experienced greater average percentage weight reductions than those beginning with a lower BMI in certain treatment groups.

Women

Women experienced greater average weight reduction than men in some of the higher-dose Phase 2 groups.

Those findings are intriguing, but they don’t mean retatrutide will ultimately be recommended only for those groups.

Individual metabolic response is highly personal.

Weight Loss Is Never Just About One Medication

This is one of the fundamental beliefs behind medical weight management at YES MD.

Your weight and body composition are influenced by:

That is why simply choosing the newest medication does not automatically create the best long-term result.

The better question is:

What does your particular body need?

Why Hormones Matter During Weight Loss

Hormonal changes can dramatically affect body composition.

Declining estrogen or testosterone may contribute to:

Thyroid dysfunction may also influence metabolism, body temperature, energy, mood and the ability to manage weight.

For appropriate patients, Dr. Ken G. Knott may evaluate these systems alongside weight-management goals.

This whole-body perspective is one of the things that distinguishes YES MD’s approach.

Tirzepatide-Semaglutide-Retatrutide-at-YES-MD-GLP1-s-Weight-Loss-in-Marietta-GA at YES MD Dr Assisted Weight Loss

Nutrition Still Matters

Powerful weight-loss therapies do not eliminate the need for good nutrition.

YES MD has decades of experience working with different nutritional approaches, including:

The goal isn’t to put every patient on the same diet.

It is to identify the eating strategy that best supports that patient’s metabolism, body composition, health and lifestyle.

Tirzepatide-Semaglutide-Retatrutide-at-YES-MD-GLP1-s-Weight-Loss-in-Marietta-GA at YES MD Dr Assisted Weight Loss

The YES MD Approach to Modern Medical Weight Loss

At YES MD in Marietta, Georgia, medical weight loss is part of a broader approach to functional wellness.

Dr. Ken G. Knott brings more than 35 years of medical experience in hormone health, thyroid optimization, metabolism and physician-guided wellness.

Dr. Knott and Rashelle Knott also bring personal experience with modern weight-management therapies, helping them understand many of the practical questions patients have while going through treatment.

Depending on the patient, a customized weight-management strategy may incorporate:

What Is the Current Status of Retatrutide?

Retatrutide remains an investigational medication being evaluated in clinical trials.

That means the science is evolving rapidly, and treatment recommendations will continue to develop as additional research becomes available.

YES MD follows these advances closely so our patients can better understand both emerging therapies and the physician-guided weight-loss options available today.

Frequently Asked Questions About Retatrutide

Retatrutide is an investigational medication being studied for obesity and metabolic disease. It acts on GIP, GLP-1 and glucagon receptors and is commonly described as a triple agonist.

Retatrutide acts on the GLP-1 pathway, but it is more accurately described as a triple agonist because it targets GLP-1, GIP and glucagon receptors.

No. Retatrutide is currently an investigational medication being studied in clinical trials and has not been approved by FDA for weight loss or any other medical condition.

Retatrutide is not currently available for routine prescription use. It is legally available through authorized clinical trials while it remains investigational.

FDA states that retatrutide currently cannot be used in compounding under federal law because it is not a component of an FDA-approved drug and does not qualify under applicable compounding provisions.

No. Tirzepatide targets GIP and GLP-1 receptors. Retatrutide targets GIP, GLP-1 and glucagon receptors and remains investigational.

Retatrutide is still being studied, so patients should not assume that it is a superior treatment. Tirzepatide is currently available in FDA-approved products for specific indications, while retatrutide remains investigational.

There is not yet a confirmed public availability date. Availability will depend on successful completion of clinical trials and the regulatory approval process.

Consumers should be cautious. FDA and Lilly have warned about unapproved retatrutide products being marketed online, including products labeled for research purposes. These products may have unknown purity, safety and dosing.

Patients interested in medical weight loss can discuss currently available options such as semaglutide or tirzepatide with a qualified medical provider, along with nutrition, hormone and thyroid evaluation and other individualized weight-management strategies.

YES MD in Marietta provides physician-guided education about current and emerging medical weight-loss therapies for patients throughout East Cobb, Kennesaw, Woodstock, Roswell and the greater Atlanta area.

Learn About Your Weight-Loss Options at YES MD

If you’re researching retatrutide because you’re ready to change your weight, metabolism and overall health, you don’t have to wait to begin that conversation.

YES MD serves patients throughout Marietta, East Cobb, Kennesaw, Roswell, Woodstock and the greater Atlanta area with individualized medical weight-management programs.

Come talk to us about:

Your Body
Your Metabolism
Your Hormones
Your Goals &
The options that make sense for you.